Literature DB >> 8928611

Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.

V Buée Scherrer1, P R Hof, L Buée, B Leveugle, P Vermersch, D P Perl, C W Olanow, A Delacourte.   

Abstract

In neurodegenerative disorders, hyperphosphorylated tau proteins aggregate into abnormal filaments. In the present study, tau protein alterations were studied in one corticobasal degeneration and seven Pick's disease cases using specific immunological probes. The typical lesions of corticobasal degeneration and Pick's disease were revealed by immunohistochemistry, including the presence of Pick bodies and achromatic swollen neurons, neuritic alterations, and neurofibrillary tangles. Tau-immunoreactive glial tangles were also observed. By immunoblotting, the case of corticobasal degeneration was characterized by the tau profile previously reported to occur in progressive supranuclear palsy with an intense labeling of the two tau 64 and 69 bands, while tau 55 was not visualized. In Pick's disease cases with Pick bodies and neurofibrillary tangles, a tau triplet similar to that encountered in Alzheimer's disease (tau 55, 64 and 69) was detected. Furthermore, a particular tau profile was found in four Pick's disease cases showing only Pick bodies and no neurofibrillary tangles. In these cases, tau 55 and 64 were strongly immunoreactive, whereas tau 69 was almost unlabeled. These differences are likely to be related to particular pools of tau isoforms present within the degenerating neurons. Since there is a great diversity of neurodegenerative disorders with substantial clinical and neuropathological overlap, the electrophoretic profile of tau proteins could represent a useful marker for the type of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8928611     DOI: 10.1007/s004010050436

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  Clinicopathological correlations in corticobasal degeneration.

Authors:  Suzee E Lee; Gil D Rabinovici; Mary Catherine Mayo; Stephen M Wilson; William W Seeley; Stephen J DeArmond; Eric J Huang; John Q Trojanowski; Matthew E Growdon; Jung Y Jang; Manu Sidhu; Tricia M See; Anna M Karydas; Maria-Luisa Gorno-Tempini; Adam L Boxer; Michael W Weiner; Michael D Geschwind; Katherine P Rankin; Bruce L Miller
Journal:  Ann Neurol       Date:  2011-08       Impact factor: 10.422

2.  Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments.

Authors:  M G Spillantini; M Goedert; R A Crowther; J R Murrell; M R Farlow; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Familial behavioral variant frontotemporal dementia associated with astrocyte-predominant tauopathy.

Authors:  Isidre Ferrer; Andrea Legati; J Carlos García-Monco; Marian Gomez-Beldarrain; Margarita Carmona; Rosa Blanco; William W Seeley; Giovanni Coppola
Journal:  J Neuropathol Exp Neurol       Date:  2015-04       Impact factor: 3.685

4.  The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains.

Authors:  M L Schmidt; T Schuck; S Sheridan; M P Kung; H Kung; Z P Zhuang; C Bergeron; J S Lamarche; D Skovronsky; B I Giasson; V M Lee; J Q Trojanowski
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

5.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

Review 6.  Challenges and new opportunities in the investigation of new drug therapies to treat frontotemporal dementia.

Authors:  Edward D Huey; Nicole Armstrong; Parastoo Momeni; Jordan Grafman
Journal:  Expert Opin Ther Targets       Date:  2008-11       Impact factor: 6.902

Review 7.  A model-based approach to understanding apraxia in Corticobasal Syndrome.

Authors:  Vessela Stamenova; Eric A Roy; Sandra E Black
Journal:  Neuropsychol Rev       Date:  2008-12-11       Impact factor: 7.444

8.  Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.

Authors:  I D'Souza; P Poorkaj; M Hong; D Nochlin; V M Lee; T D Bird; G D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  Signature tau neuropathology in gray and white matter of corticobasal degeneration.

Authors:  Mark S Forman; Victoria Zhukareva; Catherine Bergeron; Steven S-M Chin; Murray Grossman; Chris Clark; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 10.  Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Authors:  Tara M Caffrey; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.